(Q34654206)

3 August 2017

title

Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis (English)

1 reference

3 August 2017

0 references

cutaneous leishmaniasis

1 reference

Michel Vaillant

2

0 references

Pierre Buffet

object named as

Pierre Buffet

8

0 references

Piero Olliaro

1

object named as

Piero Olliaro

1 reference

3 August 2017

Byron Arana

3

1 reference

3 August 2017

Max Grogl

4

1 reference

3 August 2017

Farrokh Modabber

5

1 reference

3 August 2017

Alan Magill

6

1 reference

3 August 2017

Olivier Lapujade

7

1 reference

3 August 2017

Jorge Alvar

9

1 reference

3 August 2017

language of work or name

English

0 references

publication date

21 March 2013

1 reference

PLoS Neglected Tropical Diseases

3 August 2017

published in

1 reference

3 August 2017

volume

7

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

e2130

1 reference

Creative Commons Attribution 2.5 Generic

3 August 2017

copyright license

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Comparison of three methods for diagnosis of cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Clinical and demographic stratification of test performance: a pooled analysis of five laboratory diagnostic methods for American cutaneous leishmaniasis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Designing and reporting clinical trials on treatments for cutaneous leishmaniasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Modified intention to treat reporting in randomised controlled trials: systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Immunohistochemistry and polymerase chain reaction on paraffin-embedded material improve the diagnosis of cutaneous leishmaniasis in the Amazon region

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Interventions for American cutaneous and mucocutaneous leishmaniasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Interventions for Old World cutaneous leishmaniasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

7 July 2018

Noninferiority trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Trials to assess equivalence: the importance of rigorous methods

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Detecting alcoholism. The CAGE questionnaire

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Evaluation of PCR assay in diagnosis and identification of cutaneous leishmaniasis: a comparison with the parasitological methods.

7 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002130

Miltefosine for new world cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002130

Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002130

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002130

Design and analysis of non-inferiority mortality trials in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002130

A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002130

Group sequential clinical trials with triangular continuation regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002130

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0002130

Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

The ethics of non-inferiority trials

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3605149

Editorial: clinical trials in tropical diseases: a politically incorrect view

9 December 2018

1 reference

12 December 2020

Resistance to antimony and treatment failure in human Leishmania (Viannia) infection

1 reference

12 December 2020

A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis

1 reference

12 December 2020

Placebo Controlled Treatment of Ecuadorian Cutaneous Leishmaniasis

1 reference

12 December 2020

[Noninferiority and equivalence randomized trials: lessons and reservations--secondary publication]

1 reference

12 December 2020

American cutaneous leishmaniasis: a comparison of three sodium stibogluconate treatment schedules

1 reference

12 December 2020

Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate

1 reference

12 December 2020

The natural history of cutaneous leishmaniasis in Guatemala

1 reference

12 December 2020

The effects of non-compliance on intent-to-treat analysis of equivalence trials

1 reference

12 December 2020

Confidence intervals for a binomial proportion

1 reference

12 December 2020

Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial

1 reference

12 December 2020

Therapeutic equivalence: fallacies and falsification

1 reference

12 December 2020

Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat

1 reference

12 December 2020

10.1371/JOURNAL.PNTD.0002130

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference